TransMedics Group share price logo

TransMedics Group

NASDAQ: TMDX

Mid Cap

$79.80

+1.16

(+1.47%)

as on

TransMedics Group Stock Performance

as on October 5, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $77.14
    $80.50
    downward going graph

    3.33%

    Downside

    0.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $60.11
    $156.00
    downward going graph

    24.68%

    Downside

    95.49%

    Upside

    downward going graph

TransMedics Group share price movements today

Previous Close
$78.64
Open
$78.93
Volume
915.4K
Market Cap
$2.8B
Day's Low - High
$77.14 - $80.50
52 Week Low - High
$60.11 - $156.00

TransMedics Group Historical Returns

1 Month Return
-11.32 %
3 Month Return
+ 15.88 %
1 Year Return
-31.03 %
3 Year Return
+ 56.34 %
5 Year Return
+ 157.4 %

TransMedics Group Stock Fundamentals & Key Indicators

Check TransMedics Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8B

EPS (TTM)

4.42

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.56%

PE Ratio (TTM)

18.05

Industry PE ratio

10.48

PEG Ratio

0.17

EBITDA

120.0M

Revenue (TTM)

668.5M

Profit Margin

58.69%

Return On Equity TTM

32.97%

TransMedics Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TransMedics Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.8B157.40%18.0558.69%0.00%
Buy$49.0B-21.76%48.9477.98%0.00%
Buy$110.5B-31.34%21.1266.69%3.31%
StrongBuy$105.6B4.93%28.3165.17%1.28%
StrongBuy$168.7B-15.86%31.3556.80%2.54%

Stock Returns calculator for TransMedics Group Stock including INR - Dollar returns

The TransMedics Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

TransMedics Group investment value today

Current value as on today

₹74,870

Returns

-₹25,130

(-25.13%)

Returns from TransMedics Group Stock

-₹31,023 (-31.02%)

Dollar Impact

₹5,892 (+5.89%)

Analyst Recommendation on TransMedics Group Stock

Based on 9 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 9 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for TransMedics Group. Average target price of $97.3

TransMedics Group Share Price Target

Get share price movements and forecasts by analysts on TransMedics Group.

What analysts predicted

17.99%UPSIDE

Target Price

$97.3

Current Price

$79.8

Analyzed by

9 Analysts

High

$122

Target

$97.30

Low

$65

TransMedics Group target price $97.3, a slight upside of 17.99% compared to current price of $79.8. According to 9 analysts rating.

Indian Investors' Interest in TransMedics Group Stock

Investment in TransMedics Group Shares on INDmoney has dropped by -40.05% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-40.05% versus previous 30 day period

Search interest for TransMedics Group Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

TransMedics Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
96
114
108
121
143
157
143
160
173
189
Gross Profit
59
69
60
72
88
96
84
93
101
113
Operating Income
12
12
3
8
27
36
23
21
13
23
EBITDA
20
20
13
16
36
46
33
32
27
26
Interest Expense
3
3
3
3
3
3
3
3
7
7
Depreciation
4
4
5
5
6
6
6
7
11
-
Income Before Tax
12
12
4
6
26
36
23
21
8
19
Income Tax Expense
0
0
0
0
0
1
-1
-83
1
4
Net Income
12
12
4
6
25
34
24
105
7
14
Net Profit Margin
61.81%
60.51%
55.94%
59.21%
61.47%
61.38%
58.80%
58.11%
58.16%
59.59%

TransMedics Group Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
13
23
25
30
93
241
441
605
Gross Profit
2
5
13
16
21
65
154
262
362
Operating Income
-20
-20
-29
-26
-39
-31
-28
37
108
EBITDA
-19
-20
-27
-23
-38
-28
-7
69
148
Interest Expense
1
2
4
3
3
3
10
14
13
Depreciation
0
0
1
1
1
3
8
19
27
Income Before Tax
-20
-23
-33
-28
-44
-36
-26
35
107
Income Tax Expense
0
0
0
0
0
0
-1
0
-82
Net Income
-20
-23
-33
-28
-44
-36
-25
35
190
Net Profit Margin
27.81%
44.05%
58.73%
64.88%
69.92%
69.84%
63.77%
59.36%
59.92%

TransMedics Group Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
12
12
4
6
25
34
24
105
7
14
Operating Cash Flow
-3
25
6
19
-2
91
69
34
24
17
Investing Cash Flow
-44
-23
-47
-13
-27
-9
-7
-15
-36
-7
Financing Cash Flow
3
10
7
1
3
7
3
3
3
0
Change in Cash
-44
12
-32
6
-26
90
65
22
-8
10

TransMedics Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-23
-33
-28
-44
-36
-25
35
190
Operating Cash Flow
-23
-25
-32
-30
-28
-45
-13
48
192
Investing Cash Flow
24
12
-60
-41
29
54
-193
-129
-59
Financing Cash Flow
0
22
92
75
1
167
400
22
16
Change in Cash
2
8
0
4
0
175
193
-58
151

Global Institutional Holdings in TransMedics Group

Check out the Institutions with significant holdings in TransMedics Group.

Funds
Holdings
iShares
11.42%
Vanguard
9.07%
VANGUARD INDEX FUNDS
7.47%
Delaware Group Equity Funds V
4.78%
Fidelity Securities Fund
4.05%

TransMedics Group News & Key Events

  • img

    Today's Timeline - 10 September

    Fri, 01:35 AM

    -

    TransMedics appoints Fernando Araujo as CFO, reiterates 2026 revenue guidance of $737M to $757M.

Insights on TransMedics Group

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.31M → 14.68M (in $), with an average increase of 50.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TMDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 143.82M → 189.94M (in $), with an average increase of 8.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TMDX stock has moved up by 15.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 10.5% return, outperforming this stock by 41.5%

About TransMedics Group

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
OrganisationTransMedics Group
Headquarters200 Minuteman Road, Andover, MA, 01810, US
IndustryMedical - Devices
CEOWaleed H. Hassanein

Key Management of TransMedics Group

Name

Title

Dr. Tamer I. Khayal M.D.

Senior Vice President of International

Mr. Fernando Araujo

Chief Financial Officer & Treasurer

Mr. Matthew Forsyth

Senior VP, General Counsel & Corporate Secretary

Ms. Miriam C. Provost Ph.D.

Vice President of Global Regulatory Affairs

Dr. Waleed H. Hassanein M.D.

Founder, President, CEO & Director

Mr. Nicholas Corcoran

Senior Vice President of Supply Chain & Operations

FAQs

What is TransMedics Group share price today?

TransMedics Group share price today is $79.80 as on at the close of the market. TransMedics Group share today touched a day high of $80.50 and a low of $77.14.

What is the 52 week high and 52 week low for TransMedics Group share?

TransMedics Group share touched a 52 week high of $156.00 on and a 52 week low of $60.11 on . TransMedics Group stock price today i.e. is closed at $79.80,which is 48.85% down from its 52 week high and 32.77% up from its 52 week low.

What is TransMedics Group's market capitalisation today?

TransMedics Group market capitalisation is $0.00T as on .

How to invest in TransMedics Group Stock (TMDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TransMedics Group on INDmoney app. Click on Buy button.

What is the minimum amount required to buy TransMedics Group Stock (TMDX) from India?

Indian investors can start investing in TransMedics Group (TMDX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in TransMedics Group stock (as per the Rupee-Dollar exchange rate as on ). Based on TransMedics Group share’s latest price of $79.80 as on October 5, 2026 at 8:46 am IST, you will get 0.1253 shares of TransMedics Group. Learn more about fractional shares .

What are the returns that TransMedics Group has given to Indian investors in the last 5 years?

TransMedics Group stock has given 157.4% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?